Acute Myeloid Leukemia

Showing NaN - NaN of 91

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell

Recruiting
  • Acute Myeloid Leukemia
  • +2 more
    • Brisbane, California
    • +4 more
    Jul 18, 2022

    Myelodysplastic Syndrome, Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia Trial in Boston (biological, procedure, drug)

    Terminated
    • Myelodysplastic Syndrome
    • +2 more
    • GVAX
    • +6 more
    • Boston, Massachusetts
    • +3 more
    Jun 30, 2022

    Acute Myeloid Leukemia Trial in Boston (LY3214996)

    Recruiting
    • Acute Myeloid Leukemia
    • Boston, Massachusetts
      Dana Farber Cancer Institute
    Jun 6, 2022

    Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome Trial in Worldwide (biological, drug, procedure)

    Terminated
    • Acute Myeloid Leukemia
    • +2 more
    • ATIR101
    • +3 more
    • Duarte, California
    • +41 more
    Apr 28, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in France, United States (SY-1425 (tamibarotene), azacitidine,

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • SY-1425 (tamibarotene)
    • +2 more
    • Hartford, Connecticut
    • +25 more
    May 4, 2022

    Acute Myeloid Leukemia Trial in Canada, Puerto Rico, United States (procedure, drug, behavioral)

    Recruiting
    • Acute Myeloid Leukemia
    • Allogeneic Hematopoietic Stem Cell Transplantation
    • +13 more
    • Birmingham, Alabama
    • +187 more
    Apr 28, 2022

    Blastic Plasmacytoid Dendritic Cell Tumor, Acute Myeloid Leukemia, Acute Lymphocytic Leukemia Trial in Worldwide (IMGN632)

    Recruiting
    • Blastic Plasmacytoid Dendritic Cell Neoplasm
    • +3 more
    • Gilbert, Arizona
    • +14 more
    Apr 20, 2022

    Acute Myeloid Leukemia Trial in Boston (Usual Care, Psychological intervention)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Usual Care
    • Psychological intervention
    • Boston, Massachusetts
    • +1 more
    Apr 5, 2022

    Acute Myeloid Leukemia Trial in Worldwide (Uproleselan, Placebo)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • La Jolla, California
    • +69 more
    Apr 5, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Boston (RAD001, PKC412)

    Active, not recruiting
    • Acute Myeloid Leukemia
    • Myelodysplastic Syndrome
    • Boston, Massachusetts
    • +2 more
    Mar 28, 2022

    Acute Myeloid Leukemia, Myelodysplastic Syndrome, Acute Lymphocytic Leukemia Trial in Boston (Antithymocyte Globulin,

    Active, not recruiting
    • Acute Myeloid Leukemia
    • +6 more
    • Boston, Massachusetts
    • +1 more
    Jan 25, 2022

    Acute Myeloid Leukemia Trial in United States (SL-401)

    Terminated
    • Acute Myeloid Leukemia
    • Tampa, Florida
    • +6 more
    Jan 13, 2022

    Oncology, Acute Myeloid Leukemia Trial in United States (Open Label LAM-003)

    Completed
    • Oncology
    • Acute Myeloid Leukemia
    • Open Label LAM-003
    • New Haven, Connecticut
    • +5 more
    Dec 17, 2021

    Acute Myeloid Leukemia, Non-Hodgkin's Lymphoma, Diffuse Large B-cell Lymphoma Trial in Australia, Germany, United States

    Terminated
    • Acute Myeloid Leukemia
    • +2 more
    • Duarte, California
    • +16 more
    Dec 3, 2021

    Acute Myeloid Leukemia Trial in Canada, United States (ASP1235)

    Terminated
    • Acute Myeloid Leukemia
    • Duarte, California
    • +6 more
    Oct 28, 2021

    GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

    Recruiting
    • GVHD
    • +15 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Sep 30, 2021

    Acute Myeloid Leukemia Trial in Singapore, United States (Cytarabine, Daunorubicin, Etoposide)

    Completed
    • Acute Myeloid Leukemia
    • Palo Alto, California
    • +7 more
    Aug 6, 2021

    Philadelphia Positive Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Worldwide (STI571

    Completed
    • Philadelphia Positive Chronic Myeloid Leukemia
    • +2 more
    • STI571 400 mg
    • STI571 600 mg
    • Boston, Massachusetts
    • +11 more
    Jul 1, 2021

    Acute Myeloid Leukemia, Hematopoietic and Lymphoid System Tumor, Myelodysplastic Syndrome Trial in United States (Azacitidine,

    Recruiting
    • Acute Myeloid Leukemia
    • +5 more
    • Boston, Massachusetts
    • +3 more
    Jun 30, 2021

    Myelodysplastic Syndrome, Acute Myeloid Leukemia Trial in Boston (Lenalidomide, Velcade)

    Active, not recruiting
    • Myelodysplastic Syndrome
    • Acute Myeloid Leukemia
    • Boston, Massachusetts
    • +1 more
    Jun 22, 2021

    Acute Myeloid Leukemia Trial in Worldwide (Azacitidine, IMGN632, Venetoclax)

    Recruiting
    • Acute Myeloid Leukemia
    • Duarte, California
    • +19 more
    May 25, 2021

    Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms

    Not yet recruiting
    • Pyruvate Kinase Deficiency
    • +10 more
    • Blood Draw
    • Boston, Massachusetts
      Massachusetts General Hospital
    May 21, 2021

    Acute Myelogenous Leukemia, Acute Myeloid Leukemia Trial in Worldwide (MCLA-117 bispecific antibody)

    Active, not recruiting
    • Acute Myelogenous Leukemia
    • Acute Myeloid Leukemia
    • MCLA-117 bispecific antibody
    • Augusta, Georgia
    • +9 more
    May 6, 2021

    Acute Myeloid Leukemia, Adult Acute Monoblastic Leukemia, Adult Acute Monocytic Leukemia Trial in Canada, Puerto Rico, United

    Completed
    • Acute Myeloid Leukemia
    • +27 more
    • Caspofungin Acetate
    • +2 more
    • Birmingham, Alabama
    • +178 more
    Mar 26, 2021